Playlist


Arkadag City to Host Grand Celebrations for the National Day of the Turkmen Horse
05 Apr. 13:11During a working visit to the city of Arkadag, the National Leader of the Turkmen people and Chairman of the Halk Maslakhaty, Gurbanguly Berdimuhamedov, reviewed the preparations for the upcoming National Day of the Turkmen Horse. In a meeting with city officials and construction committee leaders, the National Leader emphasized that the festivities honoring the Akhal-Teke horses—often called the "heavenly" steeds—must be organized with the utmost prestige in the city that bears their legacy.
The Mayor of Arkadag City, G. Mammedova, reported on the extensive cleaning, landscaping, and beautification efforts taking place throughout the city. The National Leader pointed out that the celebrations should actively involve not only professional equestrians but also the general public, particularly the youth, to foster national pride and cultural continuity. The events are expected to showcase the unique beauty and speed of the Akhal-Teke breed through various exhibitions and traditional displays.
The working session also addressed the progress of the second phase of Arkadag's urban development. D. Orazov, Chairman of the State Committee for Construction, provided details on the quality of building materials and adherence to ecological standards. The National Leader stressed that ensuring high-quality construction and meeting project deadlines are critical tasks, highlighting that environmental sustainability remains a top priority for the "smart city" infrastructure.
The National Day of the Turkmen Horse in Arkadag will serve as a symbol of the nation's deep-rooted connection to its equestrian heritage. With a blend of cultural performances and modern urban aesthetics, the celebrations will reinforce the city's role as a global center for Akhal-Teke horse breeding and a beacon of Turkmenistan’s innovative development.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.